153 related articles for article (PubMed ID: 18715213)
1. Improved glycemic control in intensively treated adult subjects with type 1 diabetes using insulin guidance software.
Garg SK; Bookout TR; McFann KK; Kelly WC; Beatson C; Ellis SL; Gutin RS; Gottlieb PA
Diabetes Technol Ther; 2008 Oct; 10(5):369-75. PubMed ID: 18715213
[TBL] [Abstract][Full Text] [Related]
2. Hypoglycemia Reduction and Changes in Hemoglobin A1c in the ASPIRE In-Home Study.
Weiss R; Garg SK; Bode BW; Bailey TS; Ahmann AJ; Schultz KA; Welsh JB; Shin JJ
Diabetes Technol Ther; 2015 Aug; 17(8):542-7. PubMed ID: 26237308
[TBL] [Abstract][Full Text] [Related]
3. Glycemic Variability Is Associated with Frequency of Blood Glucose Testing and Bolus: Post Hoc Analysis Results from the ProAct Study.
Pfützner A; Weissmann J; Mougiakakou S; Daskalaki E; Weis N; Ziegler R
Diabetes Technol Ther; 2015 Jun; 17(6):392-7. PubMed ID: 25734860
[TBL] [Abstract][Full Text] [Related]
4. Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study.
Raccah D; Sulmont V; Reznik Y; Guerci B; Renard E; Hanaire H; Jeandidier N; Nicolino M
Diabetes Care; 2009 Dec; 32(12):2245-50. PubMed ID: 19767384
[TBL] [Abstract][Full Text] [Related]
5. Use of an insulin bolus advisor improves glycemic control in multiple daily insulin injection (MDI) therapy patients with suboptimal glycemic control: first results from the ABACUS trial.
Ziegler R; Cavan DA; Cranston I; Barnard K; Ryder J; Vogel C; Parkin CG; Koehler W; Vesper I; Petersen B; Schweitzer MA; Wagner RS
Diabetes Care; 2013 Nov; 36(11):3613-9. PubMed ID: 23900590
[TBL] [Abstract][Full Text] [Related]
6. Two-year efficacy and safety of AIR inhaled insulin in patients with type 1 diabetes: An open-label randomized controlled trial.
Garg SK; Mathieu C; Rais N; Gao H; Tobian JA; Gates JR; Ferguson JA; Webb DM; Berclaz PY
Diabetes Technol Ther; 2009 Sep; 11 Suppl 2():S5-S16. PubMed ID: 19772449
[TBL] [Abstract][Full Text] [Related]
7. A1c, glucose variability and hypoglycemia risk in patients with type 1 diabetes.
Guelho D; Paiva I; Batista C; Barros L; Carrilho F
Minerva Endocrinol; 2014 Jun; 39(2):127-33. PubMed ID: 24736487
[TBL] [Abstract][Full Text] [Related]
8. Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Beck RW; Riddlesworth T; Ruedy K; Ahmann A; Bergenstal R; Haller S; Kollman C; Kruger D; McGill JB; Polonsky W; Toschi E; Wolpert H; Price D;
JAMA; 2017 Jan; 317(4):371-378. PubMed ID: 28118453
[TBL] [Abstract][Full Text] [Related]
9. Mealtime 50/50 basal + prandial insulin analogue mixture with a basal insulin analogue, both plus metformin, in the achievement of target HbA1c and pre- and postprandial blood glucose levels in patients with type 2 diabetes: a multinational, 24-week, randomized, open-label, parallel-group comparison.
Robbins DC; Beisswenger PJ; Ceriello A; Goldberg RB; Moses RG; Pagkalos EM; Milicevic Z; Jones CA; Sarwat S; Tan MH
Clin Ther; 2007 Nov; 29(11):2349-64. PubMed ID: 18158076
[TBL] [Abstract][Full Text] [Related]
10. Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study.
Hirsch IB; Abelseth J; Bode BW; Fischer JS; Kaufman FR; Mastrototaro J; Parkin CG; Wolpert HA; Buckingham BA
Diabetes Technol Ther; 2008 Oct; 10(5):377-83. PubMed ID: 18715214
[TBL] [Abstract][Full Text] [Related]
11. Clinical efficacy of Professional Continuous Glucose Monitoring in improving glycemic control among children with Type 1 Diabetes Mellitus: An Open-label Randomized Control Trial.
Raviteja KV; Kumar R; Dayal D; Sachdeva N
Sci Rep; 2019 Apr; 9(1):6120. PubMed ID: 30992480
[TBL] [Abstract][Full Text] [Related]
12. Software-guided insulin dosing improves intrapartum glycemic management in women with diabetes mellitus.
Dinglas C; Muscat J; Adams T; Peragallo-Dittko V; Vintzileos A; Heo HJ
Am J Obstet Gynecol; 2018 Aug; 219(2):191.e1-191.e6. PubMed ID: 29750952
[TBL] [Abstract][Full Text] [Related]
13. Use of an automated bolus calculator reduces fear of hypoglycemia and improves confidence in dosage accuracy in patients with type 1 diabetes mellitus treated with multiple daily insulin injections.
Barnard K; Parkin C; Young A; Ashraf M
J Diabetes Sci Technol; 2012 Jan; 6(1):144-9. PubMed ID: 22401332
[TBL] [Abstract][Full Text] [Related]
14. Impact of active versus usual algorithmic titration of basal insulin and point-of-care versus laboratory measurement of HbA1c on glycemic control in patients with type 2 diabetes: the Glycemic Optimization with Algorithms and Labs at Point of Care (GOAL A1C) trial.
Kennedy L; Herman WH; Strange P; Harris A;
Diabetes Care; 2006 Jan; 29(1):1-8. PubMed ID: 16373887
[TBL] [Abstract][Full Text] [Related]
15. Exenatide versus insulin glargine in patients with suboptimally controlled type 2 diabetes: a randomized trial.
Heine RJ; Van Gaal LF; Johns D; Mihm MJ; Widel MH; Brodows RG;
Ann Intern Med; 2005 Oct; 143(8):559-69. PubMed ID: 16230722
[TBL] [Abstract][Full Text] [Related]
16. Design and rationale of the IN CONTROL trial: the effects of real-time continuous glucose monitoring on glycemia and quality of life in patients with type 1 diabetes mellitus and impaired awareness of hypoglycemia.
van Beers CA; Kleijer SJ; Serné EH; Geelhoed-Duijvestijn PH; Snoek FJ; Kramer MH; Diamant M
BMC Endocr Disord; 2015 Aug; 15():42. PubMed ID: 26292721
[TBL] [Abstract][Full Text] [Related]
17. Continued use of an integrated meter with electronic logbook maintains improvements in glycemic control beyond a randomized, controlled trial.
Laffel LM; Hsu WC; McGill JB; Meneghini L; Volkening LK
Diabetes Technol Ther; 2007 Jun; 9(3):254-64. PubMed ID: 17561796
[TBL] [Abstract][Full Text] [Related]
18. Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes.
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group
Diabetes Care; 2010 May; 33(5):1004-8. PubMed ID: 20200306
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of an algorithm to guide patients with type 1 diabetes treated with continuous subcutaneous insulin infusion on how to respond to real-time continuous glucose levels: a randomized controlled trial.
Jenkins AJ; Krishnamurthy B; Best JD; Cameron FJ; Colman PG; Farish S; Hamblin PS; O'Connell MA; Rodda C; Rowley K; Teede H; O'Neal DN
Diabetes Care; 2010 Jun; 33(6):1242-8. PubMed ID: 20215457
[TBL] [Abstract][Full Text] [Related]
20. Improved glycemic control without an increase in severe hypoglycemic episodes in intensively treated patients with type 1 diabetes receiving morning, evening, or split dose insulin glargine.
Garg SK; Gottlieb PA; Hisatomi ME; D'Souza A; Walker AJ; Izuora KE; Chase HP
Diabetes Res Clin Pract; 2004 Oct; 66(1):49-56. PubMed ID: 15364161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
